Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic choices for rheumatic disorders.

G Hughes1

  • 1Rheumatology Department, St. Thomas' Hospital, London, UK.

Gerontology
|January 1, 1988
PubMed
Summary

Elderly patients metabolize drugs differently, impacting treatment choices. Etodolac, a nonsteroidal anti-inflammatory drug (NSAID), shows clinical effectiveness with few adverse effects in older adults.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Controlling wettability of PECVD-deposited dual organosilicon/carboxylic acid films to influence DNA hybridisation assay efficiency.

Journal of materials chemistry. B·2020
Same author

Evidence for re-infection and persistent carriage of Shigella species in adult males reporting domestically acquired infection in England.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Measurement of <math></math> production with the hadronically decaying boson reconstructed as one or two jets in <i>pp</i> collisions at <math> </math> with ATLAS, and constraints on anomalous gauge couplings.

The European physical journal. C, Particles and fields·2020
Same author

Study of <math></math> and <math></math> production in <math></math> collisions at <math> </math> and search for anomalous quartic gauge couplings with the ATLAS experiment.

The European physical journal. C, Particles and fields·2020
Same author

Identification and rejection of pile-up jets at high pseudorapidity with the ATLAS detector.

The European physical journal. C, Particles and fields·2020
Same author

Measurement of detector-corrected observables sensitive to the anomalous production of events with jets and large missing transverse momentum in <math></math> collisions at <math> </math>  TeV using the ATLAS detector.

The European physical journal. C, Particles and fields·2020

Area of Science:

  • Geriatric Medicine
  • Pharmacology
  • Rheumatology

Background:

  • Elderly patients exhibit distinct drug metabolism and toxicity profiles.
  • Altered immunologic responses in older adults affect drug efficacy and safety.
  • Choosing appropriate medications for elderly rheumatic patients requires careful consideration of these factors.

Purpose of the Study:

  • To review the advantages and disadvantages of commonly used medications for elderly rheumatic patients.
  • To evaluate the efficacy and safety of nonsteroidal anti-inflammatory drugs (NSAIDs) in the elderly population.
  • To highlight etodolac as a potentially suitable NSAID for geriatric patients.

Main Methods:

  • Review of clinical data and pharmacokinetic profiles of NSAIDs.
  • Analysis of efficacy and adverse effects (gastrointestinal, hepatic, renal) of NSAIDs.
  • Focus on etodolac's properties in older patients.

Main Results:

  • NSAIDs vary in efficacy and adverse effect profiles, influencing therapeutic selection.
  • Etodolac demonstrates clinical effectiveness with a low incidence of adverse effects in elderly patients.
  • Etodolac exhibits a half-life of approximately 7 hours in older individuals, with renal excretion of metabolites and high protein binding.

Conclusions:

  • Drug selection for elderly rheumatic patients must account for age-related pharmacokinetic and pharmacodynamic differences.
  • Etodolac presents a favorable option for treating rheumatic conditions in the elderly due to its efficacy and safety profile.
  • Understanding etodolac's specific properties, such as its half-life and excretion, aids in optimizing its use in geriatric populations.

Related Experiment Videos